About us
The Vaccine and Gene Therapy Institute at Oregon Health & Science University has assembled a multidisciplinary team of scientists to respond to serious viral disease threats, including AIDS, chronic viral infection-associated diseases, newly emerging viral diseases and infectious diseases of the elderly. Our programs are intended to span the continuum between basic and clinical science, in which discoveries are rapidly advanced from the level of molecular and cellular biology through animal models and ultimately into clinical testing. Learn more
Upcoming seminars
VGTI Seminar Series and Virology Journal Club is now streamed online. Please reach out to Chad (sixkille@ohsu.edu) if you would like a link to the live stream. Only available internally to OHSU.

Recent publications
Cell Host Microbe. Sep 13, 2023
Spontaneous HIV expression during suppressive ART in associated with the magnitude and function of HIV-specific CD4+ and CD8+ T cells
J Virol. August 31, 2023
Stabilization of the human cytomegalovirus UL136p33 reactivation determinant overcomes the requirement for UL135 for replication in hematopoietic cells
J Gen Virol. August 2023
Isolation and genome sequencing of cytomegaloviruses from Natal multimammate mice (Mastomys natalensis)
Sci Immunol. July 28, 2023
Modulation of type I interferon responses potently inhibits SARS-CovV-2 replication and inflammation in rhesus macaques
Ann Neurol. July 23, 2023
Regional analysis of intact and defective HIV proviruses in the brain of viremic and virally suppressed people with HIV
Immunity. July 11, 2023
Allogeneic immunity clears latent virus following allogeneic stem cell transplantation in SIV-infected ART-suppressed macaques
Donate to VGTI
Your gifts help provide vital resources to conduct innovative research and more.


COVID-19 Efforts - Building a COVID Testing Lab